IDEXX LABORATORIES INC /DE Cost of Services (Deprecated 2018-01-31)
IDEXX LABORATORIES INC /DE (IDXX) reported Cost of Services (Deprecated 2018-01-31) of $121.04 million for the 3-month period ending 2018-06-30, per its 10-Q filed 2018-08-01.
Discontinued › Expense Statement › Cost of Sales
us-gaap:CostOfServices · last filed 2018-08-01
- IDEXX LABORATORIES INC /DE cost of services (deprecated 2018-01-31) for the quarter ending 2018-06-30 was $121.04M, a 14.30% increase year-over-year.
- IDEXX LABORATORIES INC /DE cost of services (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $116.31M, a 15.38% increase year-over-year.
- IDEXX LABORATORIES INC /DE cost of services (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $110.40M, a 14.99% increase year-over-year.
- IDEXX LABORATORIES INC /DE cost of services (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $108.13M, a 10.71% increase year-over-year.
- IDEXX LABORATORIES INC /DE cost of services (deprecated 2018-01-31) for fiscal 2017 was $425.23M, a 10.97% increase from fiscal 2016.
- IDEXX LABORATORIES INC /DE cost of services (deprecated 2018-01-31) for fiscal 2016 was $383.18M, a 9.04% increase from fiscal 2015.
- IDEXX LABORATORIES INC /DE cost of services (deprecated 2018-01-31) for fiscal 2015 was $351.41M, a 5.01% increase from fiscal 2014.
- IDEXX LABORATORIES INC /DE cost of services (deprecated 2018-01-31) for fiscal 2014 was $334.64M, a 10.72% increase from fiscal 2013.
| Period end | Cost of Services (Deprecated 2018-01-31) 3 month | Cost of Services (Deprecated 2018-01-31) 6 month | Cost of Services (Deprecated 2018-01-31) 9 month | Cost of Services (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2018-06-30 | $121.04M 10-Q · filed 2018-08-01 | $237.35M 10-Q · filed 2018-08-01 | $347.76M derived: sum of 3 quarters · filed 2018-08-01 | $455.88M derived: sum of 4 quarters · filed 2018-08-01 |
| 2018-03-31 | $116.31M 10-Q · filed 2018-05-04 | $226.71M derived: sum of 2 quarters · filed 2018-05-04 | $334.84M derived: sum of 3 quarters · filed 2018-05-04 | $440.74M derived: sum of 4 quarters · filed 2018-08-01 |
| 2017-12-31 | $110.40M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | $218.53M derived: sum of 2 quarters · filed 2018-02-16 | $324.42M derived: sum of 3 quarters · filed 2018-08-01 | $425.23M 10-K · filed 2018-02-16 |
| 2017-09-30 | $108.13M 10-Q · filed 2017-10-31 | $214.02M derived: sum of 2 quarters · filed 2018-08-01 | $314.82M 10-Q · filed 2017-10-31 | $410.83M derived: sum of 4 quarters · filed 2018-08-01 |
| 2017-06-30 | $105.89M 10-Q · filed 2018-08-01 | $206.70M 10-Q · filed 2018-08-01 | $302.71M derived: sum of 3 quarters · filed 2018-08-01 | $400.38M derived: sum of 4 quarters · filed 2018-08-01 |
| 2017-03-31 | $100.80M 10-Q · filed 2018-05-04 | $196.81M derived: sum of 2 quarters · filed 2018-05-04 | $294.48M derived: sum of 3 quarters · filed 2018-05-04 | $391.60M derived: sum of 4 quarters · filed 2018-05-04 |
| 2016-12-31 | $96.01M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | $193.68M derived: sum of 2 quarters · filed 2018-02-16 | $290.80M derived: sum of 3 quarters · filed 2018-02-16 | $383.18M 10-K · filed 2018-02-16 |
| 2016-09-30 | $97.67M 10-Q · filed 2017-10-31 | $194.78M derived: sum of 2 quarters · filed 2017-10-31 | $287.17M 10-Q · filed 2017-10-31 | $375.71M derived: sum of 4 quarters · filed 2018-02-16 |
| 2016-06-30 | $97.12M 10-Q · filed 2017-08-01 | $189.50M 10-Q · filed 2017-08-01 | $278.04M derived: sum of 3 quarters · filed 2018-02-16 | $367.97M derived: sum of 4 quarters · filed 2018-02-16 |
| 2016-03-31 | $92.38M 10-Q · filed 2017-04-28 | $180.92M derived: sum of 2 quarters · filed 2018-02-16 | $270.85M derived: sum of 3 quarters · filed 2018-02-16 | $360.23M derived: sum of 4 quarters · filed 2018-02-16 |
| 2015-12-31 | $88.54M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | $178.47M derived: sum of 2 quarters · filed 2018-02-16 | $267.85M derived: sum of 3 quarters · filed 2018-02-16 | $351.41M 10-K · filed 2018-02-16 |
| 2015-09-30 | $89.93M 10-Q · filed 2016-11-01 | $179.31M derived: sum of 2 quarters · filed 2016-11-01 | $262.87M 10-Q · filed 2016-11-01 | $347.40M derived: sum of 4 quarters · filed 2017-02-17 |
| 2015-06-30 | $89.38M 10-Q · filed 2016-08-02 | $172.95M 10-Q · filed 2016-08-02 | $257.48M derived: sum of 3 quarters · filed 2017-02-17 | $342.88M derived: sum of 4 quarters · filed 2017-02-17 |
| 2015-03-31 | $83.56M 10-Q · filed 2016-04-29 | $168.09M derived: sum of 2 quarters · filed 2017-02-17 | $253.50M derived: sum of 3 quarters · filed 2017-02-17 | $338.14M derived: sum of 4 quarters · filed 2017-02-17 |
| 2014-12-31 | $84.53M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-17 | $169.93M derived: sum of 2 quarters · filed 2017-02-17 | $254.58M derived: sum of 3 quarters · filed 2017-02-17 | $334.64M 10-K · filed 2017-02-17 |
| 2014-09-30 | $85.40M 10-Q · filed 2015-10-28 | $170.05M derived: sum of 2 quarters · filed 2015-10-28 | $250.12M 10-Q · filed 2015-10-28 | $327.35M derived: sum of 4 quarters · filed 2016-02-17 |
| 2014-06-30 | $84.65M 10-Q · filed 2015-07-30 | $164.71M 10-Q · filed 2015-07-30 | $241.95M derived: sum of 3 quarters · filed 2016-02-17 | $317.94M derived: sum of 4 quarters · filed 2016-02-17 |
| 2014-03-31 | $80.06M 10-Q · filed 2015-04-28 | $157.30M derived: sum of 2 quarters · filed 2016-02-17 | $233.29M derived: sum of 3 quarters · filed 2016-02-17 | $308.34M derived: sum of 4 quarters · filed 2016-02-17 |
| 2013-12-31 | $77.24M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-17 | $153.23M derived: sum of 2 quarters · filed 2016-02-17 | $228.27M derived: sum of 3 quarters · filed 2016-02-17 | $302.25M 10-K · filed 2016-02-17 |
| 2013-09-30 | $75.99M 10-Q · filed 2014-10-24 | $151.04M derived: sum of 2 quarters · filed 2014-10-24 | $225.02M 10-Q · filed 2014-10-24 | $296.02M derived: sum of 4 quarters · filed 2015-02-17 |
| 2013-06-30 | $75.04M 10-Q · filed 2014-07-25 | $149.03M 10-Q · filed 2014-07-25 | $220.02M derived: sum of 3 quarters · filed 2015-02-17 | $292.13M derived: sum of 4 quarters · filed 2015-02-17 |
| 2013-03-31 | $73.98M 10-Q · filed 2014-04-25 | $144.98M derived: sum of 2 quarters · filed 2015-02-17 | $217.08M derived: sum of 3 quarters · filed 2015-02-17 | $289.57M derived: sum of 4 quarters · filed 2015-02-17 |
| 2012-12-31 | $71.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-17 | $143.10M derived: sum of 2 quarters · filed 2015-02-17 | $215.59M derived: sum of 3 quarters · filed 2015-02-17 | $288.28M 10-K · filed 2015-02-17 |
| 2012-09-30 | $72.10M 10-Q · filed 2013-10-22 | $144.59M derived: sum of 2 quarters · filed 2013-10-22 | $217.28M 10-Q · filed 2013-10-22 | $283.80M derived: sum of 4 quarters · filed 2014-02-18 |
| 2012-06-30 | $72.49M 10-Q · filed 2013-07-23 | $145.18M 10-Q · filed 2013-07-23 | $211.70M derived: sum of 3 quarters · filed 2014-02-18 | $277.15M derived: sum of 4 quarters · filed 2014-02-18 |
| 2012-03-31 | $72.69M 10-Q · filed 2013-04-23 | $139.21M derived: sum of 2 quarters · filed 2014-02-18 | $204.66M derived: sum of 3 quarters · filed 2014-02-18 | $271.04M derived: sum of 4 quarters · filed 2014-02-18 |
| 2011-12-31 | $66.52M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-18 | $131.97M derived: sum of 2 quarters · filed 2014-02-18 | $198.35M derived: sum of 3 quarters · filed 2014-02-18 | $262.39M 10-K · filed 2014-02-18 |
| 2011-09-30 | $65.46M 10-Q · filed 2012-10-19 | $131.83M derived: sum of 2 quarters · filed 2012-10-19 | $195.87M 10-Q · filed 2012-10-19 | $256.69M derived: sum of 4 quarters · filed 2013-02-19 |
| 2011-06-30 | $66.37M 10-Q · filed 2012-07-20 | $130.41M 10-Q · filed 2012-07-20 | $191.24M derived: sum of 3 quarters · filed 2013-02-19 | $251.58M derived: sum of 4 quarters · filed 2013-02-19 |
| 2011-03-31 | $64.04M 10-Q · filed 2012-04-20 | $124.86M derived: sum of 2 quarters · filed 2013-02-19 | $185.21M derived: sum of 3 quarters · filed 2013-02-19 | $245.34M derived: sum of 4 quarters · filed 2013-02-19 |
| 2010-12-31 | $60.82M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-19 | $121.17M derived: sum of 2 quarters · filed 2013-02-19 | $181.30M derived: sum of 3 quarters · filed 2013-02-19 | $238.83M 10-K · filed 2013-02-19 |
| 2010-09-30 | $60.34M 10-Q · filed 2011-10-21 | $120.48M derived: sum of 2 quarters · filed 2011-10-21 | $178.01M 10-Q · filed 2011-10-21 | $236.49M derived: sum of 4 quarters · filed 2012-02-17 |
| 2010-06-30 | $60.13M 10-Q · filed 2011-07-22 | $117.67M 10-Q · filed 2011-07-22 | $176.14M derived: sum of 3 quarters · filed 2012-02-17 | $233.24M derived: sum of 4 quarters · filed 2012-02-17 |
| 2010-03-31 | $57.53M 10-Q · filed 2011-04-21 | $116.00M derived: sum of 2 quarters · filed 2012-02-17 | $173.10M derived: sum of 3 quarters · filed 2012-02-17 | $229.08M derived: sum of 4 quarters · filed 2012-02-17 |
| 2009-12-31 | $58.48M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-17 | $115.58M derived: sum of 2 quarters · filed 2012-02-17 | $171.55M derived: sum of 3 quarters · filed 2012-02-17 | $224.31M 10-K · filed 2012-02-17 |
| 2009-09-30 | $57.10M 10-Q · filed 2010-10-22 | $113.08M derived: sum of 2 quarters · filed 2010-10-22 | $165.83M 10-Q · filed 2010-10-22 | |
| 2009-06-30 | $55.98M 10-Q · filed 2010-07-23 | $108.73M 10-Q · filed 2010-07-23 | ||
| 2008-12-31 | $224.10M 10-K · filed 2011-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |